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Highlights 
 First comparison of bovine tuberculosis test performance estimated by meta-
analyses 
 Sensitivity estimate of single comparative cervical tuberculin test moderate or 
low 
 Wide credible intervals for estimates suggests heterogeneity in performance  
 
 
Abstract 
Bovine Tuberculosis (bTB) in cattle is a global health problem and eradication of the disease 
requires accurate estimates of diagnostic test performance to optimize their efficiency. The 
objective of this study was, through statistical meta-analyses, to obtain estimates of 
sensitivity (Se) and specificity (Sp), for 14 different ante-mortem and post-mortem diagnostic 
tests for bTB in cattle. Using data from a systematic review of the scientific literature 
(published 1934-2009) diagnostic Se and Sp were estimated using Bayesian logistic 
regression models adjusting for confounding factors. Random effect terms were used to 
account for unexplained heterogeneity. Parameters in the models were implemented using 
Markov Chain Monte Carlo (MCMC), and posterior distributions for the diagnostic 
parameters with adjustment for covariates (confounding factors) were obtained using the 
inverse logit function. Estimates for Se and/or Sp of the tuberculin skin tests and the IFN-γ 
blood test were compared with estimates published 2010-2015. Median Se for the single 
intradermal comparative cervical tuberculin skin (SICCT) test (standard interpretation) was 
0.50 and Bayesian credible intervals (CrI) were wide (95% CrI 0.26, 0.78). Median Sp for the 
SICCT test was 1.00 (95% CrI 0.99, 1.00). Estimates for the IFN-γ blood test Bovine Purified 
Protein Derivative (PPD)-Avian PPD and Early Secreted Antigen target 6 and Culture 
Filtrate Protein 10 (ESAT-6/CFP10) ESAT6/CFP10 were 0.67 (95% CrI 0.49, 0.82) and 0.78 
(95% CrI 0.60, 0.90) respectively for Se, and 0.98 (95% CrI 0.96, 0.99) and 0.99 (95% CrI 
0.99, 1.00) for Sp. The study provides an overview of the accuracy of a range of 
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contemporary diagnostic tests for bTB in cattle. Better understanding of diagnostic test 
performance is essential for the design of effective control strategies and their evaluation. 
 
Keywords: bovine tuberculosis, diagnostic tests, meta-analysis, performance, sensitivity, 
specificity 
 
Introduction 
Bovine tuberculosis (bTB) is endemic in cattle in many parts of the world resulting in 
substantial social and economic costs (Cousins, 2001, OIE, 2012, Defra, 2014). The disease 
is difficult to eradicate particularly where it has become endemic in a wildlife population, as 
in the case of the United Kingdom (UK) and the Republic of Ireland (RoI) (Abernethy et al., 
2013, Godfray et al., 2013, More and Good, 2015). Mathematical modelling suggests that a 
substantial impact on the current epidemic in Great Britain (GB) could be achieved within a 
national eradication and control strategy through improvements in the detection of infected 
cattle and herds, with consequential reduction in cattle-to-cattle transmission (Cox et al., 
2005, Defra, 2014, Brooks-Pollock and Wood, 2015, Moustakas and Evans 2015). The 
development of new and improved diagnostic tests for bTB as well as better targeting of tests 
is an important part of bTB research (de la Rua-Domenech et al., 2006, Schiller et al., 2010, 
Bezos et al., 2014, Brooks-Pollock and Wood, 2015). 
 
The choice of diagnostic test and cut-off value used for defining an animal as infected is a 
trade-off between the need for sensitivity (Se) and specificity (Sp) within the local 
epidemiological context whilst meeting statutory requirements (EEC.,1964, de la Rua-
Domenech et al., 2006, ESFA, 2012). High Se will maximise the likelihood of detecting 
infected animals but in low prevalence disease situations, high Sp is important to reduce the 
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number of false positive test results and therefore the number of healthy animals culled. Se 
and Sp are not only functions of the active diagnostic component of tests and the choice of 
diagnostic cut-off value, but may also be affected by the immunological profile of the host 
animal such as stage of infection, and local factors such as availability of laboratory facilities, 
training and experience of testers (EFSA, 2012). Concurrent infections and 
immunosuppression due to previous tests of the host can also influence the test results by 
reducing the sensitivity (Coad et al., 2010, Broughan et al., accepted). The presence of other 
mycobacteria in the environment may reduce specificity because of cross-reactivity with the 
test diagnostics (Aagaard et al., 2010, Coad et al., 2012). Se and Sp estimates also depend on 
the accuracy of the reference test (the evidence or “gold standard” used to determine whether 
an animal is truly infected) unless Latent Class Analysis (LCA) is conducted.  
 
Probability distributions are used to describe the uncertainty produced in Se and Sp estimates 
due by factors such as the characteristics of the host animal, the test characteristics (and those 
of a reference standard if used) and local conditions. Statistical meta-analysis combining 
estimates of Se or Sp from different studies offers an approach to evaluate test performance 
whilst explicitly adjusting for heterogeneity caused by the factors described above. When 
conducted within a Bayesian framework, it also allows the inclusion of prior knowledge into 
the statistical inference. Furthermore, the Markov chain Monte Carlo (MCMC) simulation 
technique generates the empirical posterior distributions explicitly, which is another 
advantage since no distributional assumptions about Se and/or Se are required.  
 
Reviews of diagnostic tests for bTB in cattle exist (de la Rua-Domenech et al., 2006, Schiller 
et al., 2010, Bezos et al., 2014). However, there has only been one published attempt to 
summarise data from the literature and generate summary estimates through meta-analysis 
Nunez-Garcia et al., 2.0 Meta-analysis 7/1/2017 v6.0 
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and this was limited to the caudal fold skin test, which is used in field surveillance in USA, 
New Zealand and Australia (Farnham et al., 2012). The objective of the current study was to 
estimate Se and Sp for 14 different ante-mortem and post-mortem diagnostic tests for bTB in 
cattle through a meta-analysis of data extracted as part of a systematic review of the literature 
(Downs et al., 2017b). 
Materials and methods 
Data source for estimates of sensitivity and specificity  
The data for the meta-analysis were derived from references with estimates of Se and Sp of 
ante-mortem and post-mortem tests that had been identified in the systematic review 
(described in detail in Downs et al., 2017b). Briefly, a standardised two-stage process of 
review with extraction of relevant data was developed and agreed by an expert Working 
Group (WG). In stage 1, a comprehensive search strategy was developed to identify studies 
reporting the performance (Se and/or Sp) of diagnostic tests in cattle naturally exposed to 
bTB. Abstracts to references were reviewed against predetermined inclusion and exclusion 
criteria. Stage 2 comprised a more detailed review of references selected at stage 1 and 
involved reading the entire reference to determine whether the study was eligible for 
inclusion based on agreed criteria. If a study was eligible for inclusion in the meta-analysis, 
numerator (number that tested positive or negative) and denominator (number of true 
positives or negatives) data for the estimation of Se and Sp and covariate information were 
extracted and stored in a bespoke database.  After resolving differences between decisions by 
reviewers who reviewed the same references, two datasets, one containing Se data and the 
other containing Sp data from the eligible studies were compiled. Thus, each record in the 
datasets included: test type, a numerator and denominator from which Se (or Sp) could be 
calculated and covariate data. The range of covariates for which data were extracted from 
references had been identified a priori by the WG before the review process commenced. Se 
Nunez-Garcia et al., 2.0 Meta-analysis 7/1/2017 v6.0 
 7 
was calculated as the ratio of the number of the test positives and number of the true 
positives, and Sp was calculated as the ratio of the number of the test negatives and true 
negatives.  
 
Some references reported more than one estimate of Se (or Sp) for a particular test type in the 
same population due to implementing different test modifications or cut-offs. In order to 
compensate for the fact that the same population may have been be used to calculate several 
performance estimates, an artificial covariate to weight the records according to the number 
of performance estimates reported using the same population was added to the database. For 
example, if a reference reported three Se estimates for the same test type over the same 
population, three records would have been added to the database. The three records would 
show the same population size covariate value, different test modification covariate value and 
the artificial covariate equal to 1/3. Introducing the artificial covariate allowed the use of the 
estimates reported within a reference without the population size being over-represented.  
 
Removal of outliers 
The data set for each diagnostic test type was explored for outliers using an iterative 
algorithm based on the chi-square distribution of the squared differences between the Se (or 
Sp) values and their mean value (Edwards et al., 1963). A very low threshold p-value equal to 
0.001 for significance was set to exclude the most extreme values. 
 
Selection and adaptation of covariates 
The selection of covariates had been made by the WG prior to the review of potential 
references with performance estimates (Downs et al., 2017b). However, the covariates 
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included in the modelling were limited to those reported in all references with eligible 
performance estimates within each test-type (Table 3).  
 
The modelling approach taken in this meta-analysis study, where Se and Sp were estimated 
through implementing two independent models, has been used previously (EFSA, 2006, 
2008, Greiner et al., 2000). In this study however, both models were related by a counter-
parameter defined as a covariate (pertaining to the same study and diagnostic test) that 
contained the corresponding Sp estimates for the Se modelling, and the corresponding Se 
estimates for the Sp modelling. For estimates where a counter-parameter was missing, i.e. 
estimates within the Se data set for which the Sp estimate was not reported in the reference 
(or vice versa), the median, calculated from all estimates from references for the test-type, 
was imputed.    
 
All covariates, except the continuous counter-parameter, were transformed into binary 
variables with values 0 or 1. Value 1 represented the most preferred category or the category 
most applicable to current use of the test in UK and Ireland (baseline category). Value 0 
represented the remaining complementary categories). For example, for the year of 
publication covariate, records corresponding to papers published between 2000 and 2009 
were given a value equal 1, as the WG preferred the final estimate being based on the most 
recent publications. The remaining records were then set to 0. As a consequence of the binary 
coding, information associated to categories coded to 0 would be lost. However, this 
approach was justified by the gain in power and more robust analysis for the relatively small 
number of studies in each meta-analysis.  
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Covariates with low variability, where the proportion between the two dichotomous values 
was more extreme than 10% - 90%, were not included in the modelling. The threshold range 
of proportions of 10% - 90% was chosen as a compromise in order to only exclude covariates 
presenting very low variability. As a consequence, if a covariate is thus excluded, the results 
for the meta-analysis need to be interpreted as “mainly” applicable for the condition 
represented by the highest proportion. More severe threshold proportions (e.g. 30% - 70%) 
might produce more parsimonious models albeit with the penalty of a greater loss of 
information related to the excluded covariates. The opposite effect would apply with a less 
severe threshold.     
 
Logistic regression modelling within a Bayesian Framework 
The model used in this study was based on the logistic regression model with a random effect 
to account for the heterogeneity not explained by the model covariates. This is; logit(Se) = z 
+ βX, where the random effect term z = N(µ,τ) and µ = N(0, σ). Parameters τ and σ were the 
variance within and between studies. Parameter β was the vector of parameters and X the 
matrix of covariates. To measure the effect of a baseline category for a particular covariate Xi  
in the final estimate, the odds ratio exp(βi) was used (the ratio between the products Se (1-Se) 
and Se βi(1- Se βi) where Se βi is the Se estimate using the same model but excluding covariate 
Xi).  
 
The modelling was run within a Bayesian framework by implementing the MCMC method 
for parameter estimation using WinBugs in the R environment (Lunn et al., 2000) essentially 
as described elsewhere (Hornick, 2011, Thomas et al., 2006). Two approaches were 
considered for estimating priors: first, requesting experts to provide performance estimates 
that could be used as priors, and second, generating priors from references where 
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performance could be estimated using LCA. The first approach was discarded after 
discussion within the WG; previous work (EFSA, 2008) had shown that relatively few 
experts are willing to commit to estimates of diagnostic test performance. With regard to the 
second approach, only six references were identified where test performance could be 
estimated through LCA (Downs et al., 2017b). The effect of using LCA estimates as priors 
was explored. However, with the removal of these references from the main data-set, the 
sample size for specific test-types became small and the priors had an excessive influence on 
the posterior distributions. For these reasons, it was agreed that non-informative or flat priors 
in the context of the regression parameter would be used and these were set to dnorm 
(0,0.001) in all models.  
 
For each MCMC iteration, a logit(Se) value was obtained. The corresponding Se estimate 
was then calculated by applying to this value the inverse logit function (given by equation 
exp(x)/(1+exp(x) where x = logit(Se)). The posterior distribution for Se was calculated as the 
density function of the values obtained from the inverse logit for all the MCMC iterations. 
The median value of the posterior distribution for Se was chosen as the point estimate and the 
Bayesian credible interval was also reported. Using the posterior distribution for the model 
parameters, a covariate was considered significant if its corresponding 95% credible interval 
did not contain zero. 
 
Based on our experiences running these MCMC models, the burn-in and model update 
iterations were set depending on the number (p) of parameters in the model as 200*p and 
800*p2, respectively. This approach provides an automated method to achieve convergence 
within a known time frame. Nevertheless, convergence of the process was monitored visually 
for three independent MCMC chains. 
Nunez-Garcia et al., 2.0 Meta-analysis 7/1/2017 v6.0 
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There were several cases where it was desirable to calculate estimates for Se based on 
different baseline categories for a particular covariate, for example where test performance 
had been estimated for different diagnostic antigens. In these cases, the binary coding and the 
modelling process were repeated for each of the different conditions. These were: for ELISA 
test-type, for covariate Purified Protein Derivative (PPD, tuberculin extracted from specific 
strains of Mycobacteria) the baseline category was set to Bovine, then to Bovine-Avian, and 
then to MPB70; for IFN-γ test-type, for covariate PPD, baseline categories were set to 
Bovine, Bovine-Avian, ESAT6-CFP10 and MPB70; for the necropsy test-type baseline 
categories were set to laboratory and meat inspection and for SICCT test-type, baseline 
categories were set to severe and standard interpretation. See Tables 4 and 5. 
 
Two modelling approaches 
In modelling approach (A), a set of covariates was selected a priori by the WG as influential 
to the final performance estimates. Then, a preliminary analysis to investigate the 
associations between Se and these covariates using a stepwise logistic regression (with fixed 
effects) was carried out. Covariates that remained in the models were selected for a Bayesian-
MCMC logistic modelling with a random effect (REM) as described above. Table 1 and 
Table 2 show the covariates included in the models and whether or not they are significant. 
For test-types with few estimates, convergence was not always achieved. For the latter cases, 
a basic estimate for Se was generated by applying the same modelling approach but using a 
simplified fixed effect model (FEM) with no covariates included.  
 
The second modelling approach (B) was applied to the test-types with a successful REM in 
approach A. This consisted of an iterative algorithm to compute all the models for all 
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possible combinations of covariates. The model with the highest number of significant 
covariates was then selected. If a tie occurred, the model with the lowest deviance 
information criterion (DIC) (Spiegelhalter et al., 2002) was selected. DIC values were also 
used to compare performance between models A and B.  
 
Note that the same modelling approach described above for Se was also applied for the Sp. 
 
Results  
Denominator and numerator data for estimating Se and/or Sp for 14 different diagnostic test 
types were extracted from 119 references identified as having eligible data during the 
systematic review (Downs et al., 2017b). The number of Se and Sp estimates varied between 
test-types and ranged from 1 to 166 (Tables 4 and 5). Two and six estimates that were 
identified as outliers for Se in the caudal fold test and IFN-γ blood test respectively were 
removed from respective datasets before the statistical modelling was conducted.  
 
Covariates 
The initial number of covariates extracted from each reference varied from 30 to 51 and from 
27 to 42 per Se and Sp estimate respectively. Only covariates consistently measured within 
all references for a test type were included in the models. Up to 17 and 12 covariates for Se 
and Sp respectively were included in initial models but many were eliminated during the 
logistic regression analysis (Tables 1, 2 and 3). Eighty percent of references that reported at 
least one Sp estimate for IFN-γ or ELISA and 76.6% of references that reported at least one 
Se estimate for IFN-γ or ELISA did not indicate a preferred diagnostic cut-off value for a 
positive response to the test. Choice of reference standard, sampling strategy (random or 
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census-based compared to other) and the counter estimate of Sp (when modelling Se) and the 
counter estimate of Se (when modelling Sp) were influential in virtually all models.  
 
Estimates for sensitivity and specificity by test type 
Pooled unadjusted estimates for Se and Sp and estimates weighted by population size and 
posterior distributions from logistic regression with MCMC modelling with covariates set for 
UK and Irish conditions, are reported in Tables 4 and 5 (further detail in the online 
supplement).  
 
Test performance estimates from modelling procedure A  
The posterior distributions for estimates of Se had wide credible intervals due to the large 
amount of heterogeneity unexplained by the models and it was not possible to demonstrate 
statistically that the estimates from different tests were significantly different from one 
another (Table 4). Credible intervals were narrower for the Sp estimates (Table 5).  
 
Ante-mortem tests 
The highest median sensitivity in the tuberculin skin tests was for the SIT test (0.94 for 
Model A and 0.81 for Model B). The median sensitivity of the SICCT test at standard 
interpretation was 0.50 (Model A) and 0.63 (model B). This difference is a consequence of 
including covariates year of publication, PPD manufacturer and number of reviewers in 
model A and not in model B (See Table 1, Table 2 and online supplement).  Sensitivity of the 
caudal fold test was lower than that for the SIT test but higher than for the SICCT test, both 
at standard and severe interpretation (Table 4).   
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None of the median Se estimates for the IFN-γ or ELISA blood tests was higher than the 
estimate for the SIT test. The median estimates for Se of the IFN-γ blood tests were higher 
and the width of the credible intervals narrower than for the serological ELISA with 
equivalent diagnostic antigens. The median Se for IFN-γ Bovine PPD - Avian PDD was 
higher than the Se for the SICCT test at standard interpretation. The median estimates for Se 
of the IFN-γ ESAT6/CFP10 was slightly lower than that for the IFN-γ Bovine, but higher 
than both comparative PPD tests (the SICCT test and IFN-γ Bovine PPD – Avian PPD). In 
general, the width of the credible intervals were narrower for the IFN-γ blood tests than for 
the skin tests but there was considerable overlap of the credible interval between test-types 
except for IFN-γ using MPB70 which had the lowest Se of all the tests.  
 
The SICCT test at standard interpretation and the caudal fold test had the highest median Sp 
of all the ante-mortem tests (Table 5). Sp distributions for the IFN-γ blood tests were 
narrower than those estimated for the ELISA and the median estimates slightly lower. The 
median estimate for Sp of ESAT/CFP10 was the highest of all the IFN-γ tests and higher than 
the SIT. The estimates for the Sp of both the LBAA and the rapid test had wide credible 
intervals. The only estimate for Sp of LBAA was lower than all the median estimates for Sp 
of the IFN-γ blood tests apart from with the MPB70 diagnostic antigen.   
 
Post-mortem tests 
Detailed laboratory necropsy had the highest median Se of all the post-mortem tests (0.96) 
and ante-mortem tests (Table 4). The median Se for meat inspection in the slaughterhouse 
was substantially lower and estimated Se for PCR was very low. Sp was estimated to be 
perfect for meat inspection, PCR and microscopic examination and 0.99 for culture. 
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Test performance estimates from modelling procedure B  
The models generated through automated selection of covariates were more parsimonious 
than the models for the equivalent tests achieved through procedure A. The distribution of the 
credible intervals were generally narrower for model B compared to model A for the 
equivalent test types. Covariates sampling method, region, year of publication and post-
mortem type were included in model A but not in model B. While most estimates using 
procedures A and B were similar, there were a few that were considerably different.  All Se 
for the comparative PPD tests (SICCT test, IFN-γ Bovine PPD – Avian PPD, ELISA Bovine 
PPD – Avian PPD) were higher with model B. As an extreme example, Model A generated 
an estimation of Se of PCR of 0.14 whereas the median estimates using model B was 0.86. 
This difference was due to the inclusion of production type in model A (not selected during 
automated procedure B) in model A in which dairy cattle were set to baseline. There were 
two Se estimates in dairy cattle with strong leverage, although they had not been identified as 
outliers.  
 
Discussion 
Meta-analyses were conducted to summarise estimates of performance for diagnostic tests for 
bTB in cattle obtained through a comprehensive systematic review (Downs et al., 2017b). 
The analyses used similar methodology to earlier work evaluating bTB tests in deer (EFSA, 
2008), and the study is the first to evaluate and compare the performance of a range of ante-
mortem and post-mortem diagnostic tests for bTB in cattle using a meta-analysis approach. In 
estimating the Se and Sp from studies published between 1934 and 2009, the study provides 
an overview of the accuracy of different tests used to diagnose bTB in cattle.  
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The SICCT test at standard interpretation was estimated through the meta-analysis to have a 
median Se of 0.50 (95% CrI 0.26, 0.78) by model A and 0.64 (95% CrI 0.48, 0.78) by model 
B (Table 4). These estimates can only be described as low or moderate, which is of concern 
given the widespread use of SICCT test and its official status as a standalone test (EEC, 
1964).  However, the credible intervals on both estimates were wide. Since the meta-analysis 
was conducted, the Se of the SICCT test has been estimated as 0.81 (95% 0.70-0.89) using 
data from herds that were subject to depopulation in GB between 1988 and 2008 
(Karolemeas et al., 2012 and Table 6) and six Se estimates have been reported in studies 
using LCA (Figure 1). The Se estimate from the whole herd slaughters was considerably 
higher than the estimates from the meta-analysis (Tables 4 and 6). In these circumstances, 
infected animals are likely to have developed significant pathology, which means post-
mortem confirmation of infection (and therefore estimated Se) is likely to have been higher 
than in the SICCT test positive cattle detected through routine surveillance. In fact, inclusion 
of the whole herd slaughter data, kindly made available to us by the authors, made minimal 
difference to the Se estimates. The revised median Se estimates at standard interpretation 
from modelling procedures A and B were 0.49 (95% CrI 0.27, 0.74) and 0.65 (95% CrI 0.52, 
0.77) respectively. Comparison with the LCA studies show that the meta-analysis estimates 
are at the lower end of the spectrum for reported Se of the SICCT test although not 
statistically significantly different (Figure 1).  
 
It is possible that UK and RoI conditions give rise to lower Se in tests based on the response 
to PPD. PPD consists of an ill-defined mixture of proteins, and some of its antigenic 
components are present in non-pathogenic environmental bacteria (Dunn et al., 2005, Tameni 
et al., 1998). Subtle changes in M. bovis related to intense surveillance and control strategies 
may have favoured survival of strains of the bacterium better able to evade the test (Smith et 
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al., 2006). Between 20-50% of reactors to the SICCT test detected during surveillance in GB 
have post mortem evidence of infection (de la Rua-Domenech et al., 2006). However, the 
high specificity of the SICCT test suggests that a large proportion of SICCT test positive 
cattle detected are truly infected. The specificity of SICCT test estimated through the meta-
analysis was consistent with a recent estimation of Sp using GB surveillance data, in which  
freedom from M. bovis infection in cattle was based on geographical distance from confirmed 
infected herds (Goodchild et al., 2015) (Table 7); and also four other estimates from studies 
using LCA (Figure 2). Another LCA by Hartnack et al., 2012 has reported a specificity of 
less than 0.70 for the SICCT test (at standard interpretation) but the study population 
included a group of non-reactor cattle purposively selected from herds that had persistent 
recurring bTB incidents (Downs et al., 2008).   
 
A meta-analysis of the performance of the CF skin test in the USA reports summary Se 
(weighted mean 0.859) and Sp (weighted mean 0.926) estimates that are broadly consistent 
with the meta-analysis distributions (Farnham et al., 2012, Tables 4 and 5).   
 
The meta-analysis results suggested that the IFN-γ blood test using PPD has similar or higher 
Se than most other tests including the tuberculin skin tests and the ELISA antibody tests 
using PPD. Se estimates reported for the IFN-γ blood test using Bovine PPD -Avian PPD 
since 2009 are slightly higher than the median estimates reported in the meta-analysis but 
within the observed credible intervals (Tables 4 and 6). The same pattern is seen when the 
meta-analysis results are compared to estimates calculated through LCA since 2009 (Figure 
1).  
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The Sp of the IFN-γ blood test with PPD estimated by meta-analysis was over 0.90 and 
similar to estimates reported since 2009 (Table 7 and Figure 2) although not as high as the Sp 
of the SICCT test. A number of studies have shown that the tuberculin skin test and IFN-γ 
test using PPD detect overlapping yet partly distinct populations (Neill et al., 1994, Coad et 
al., 2008). Since 2009, point estimates for Sp for the IFN-γ blood test with PPD of less than 
0.70 has been calculated through LCA in two studies (Figure 2). A possible explanation for 
the lower Sp estimates in the LCA studies compared to the meta-analysis is differences in 
infection prevalence between studies.    
 
 
The IFN-γ blood test with early secretory antigen target 6kDa (ESAT6) and culture filtrate 
protein 10 (CFP10) showed as good or slightly better Se than the IFN-γ using PPD 
suggesting that this defined antigen on its own or in combination with other antigens could 
have a role in bTB surveillance and control strategies (see also EFSA, 2012). There is also 
evidence in the literature that ESAT6/CFP10 may have considerable advantages over PPD 
based tests where cross-reactivity with other mycobacteria such as M. avium ssp 
paratuberculosis could be a problem (Aagard et al., 2010). Small modifications in test 
platform (such as whether the antigens are presented as a protein and peptide cocktail) can 
affect performance (Schiller et al., 2009, Casal et al., 2014) although we were not able to 
control for these differences in the meta-analysis. Skin tests have now been developed with 
ESAT6 and CFP10 (Table 6 and 7). 
 
The anti-body detection based ELISAs generally had lower accuracy than the tuberculin skin 
tests and the IFN-γ test. Considerable variability in estimates from 2010-2015 was observed 
(Tables 6 and 7). Since the ELISAs detect a serological response, sensitivity is likely to be 
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higher when evaluated in animals with later stage disease with macroscopic lesions, which is 
also when the animals are likely to be their most infective (Casal et al., 2014). It should also 
be noted that given that PPD-based skin tests are known to boost antibody responses 
(Lightbody et al., 2000), the use of antibody tests in the absence of skin-test surveillance 
would likely reduce their Se estimates further.  
 
The hierarchy of the Se estimates for post-mortem tests was generally in the direction 
anticipated. Detailed laboratory post-mortem had a higher Se than the other post-mortem 
tests. Unsurprisingly microscopic examination was less sensitive than meat inspection or 
detailed post-mortem since all the reference standards for microscopy were laboratory 
necropsy, meat inspection or culture (Downs et al., 2017b). Correlation between the post-
mortem tests and reference standards commonly used in their evaluation is likely to be higher 
than between the ante-mortem tests and reference standards because these reference standards 
are predominantly post-mortem tests (Downs et al., 2017b). This may have biased estimates 
of Se of post-mortem tests upwards compared to ante-mortem tests and may explain why the 
Se of detailed laboratory post-mortem was higher than that of all ante-mortem tests and Se of 
meat inspection higher than that of the SICCT test. 
 
Meta-analysis has been more commonly used for summarising effects from therapeutic 
interventions than for estimating diagnostic test performance. A specialised approach is 
required because of the non-normal distribution of Se and Sp and the need to build separate 
regression models (Harbord et al., 2007). Separate regression modelling procedures for the 
two performance characteristics have also been conducted in other meta-analyses for 
diagnostic tests (Midgette et al. 1993, Greiner et al., 2009, Jones and Athanasiou 2005, 
Rosman and Korsten 2007, EFSA, 2006, EFSA, 2008). The regression approach, in contrast 
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to other models (Moses et al., 1983; Irwig et al., 1995), can accommodate studies that 
contribute more than one parameter (Se, Sp) estimate. Over 10% of references measuring the 
performance of IFN-γ blood test with Bovine PDD - Avian PPD diagnostic antigens reported 
at least seven estimates for Se and 19 estimates for Sp. Factors, for which there was available 
information and that might explain differences in performance estimates were included in the 
models and the estimates for Se and Sp were modelled to be as relevant as possible to test 
conditions in the UK and the RoI.  
 
As well as extracting performance data, reviewers assessed whether studies were 
methodologically sound (Downs et al., 2017a). This investigation showed that most of the 
studies of diagnostic test performance identified in the review had some methodological 
deficiencies, regardless of test-type. Common problems across all test types, which could bias 
assessments included awareness of the index diagnostic test results when performing the 
reference test (and vice-versa) and absence of information about animal withdrawals and un-
interpretable study results (Downs et al., 2017a). Se and Sp estimates were not weighted by a 
quality score in the meta-analysis because of the difficulty in designing an informative and 
neutral score across different test types (Whiting et al., 2005, Leeflang et al., 2008). 
Publication bias is another issue that could have affected estimates. However, we conducted a 
comprehensive and systematic search of both published and grey literature and standardised 
our data extraction protocol (Irwig et al., 1994, Stroup et al., 2000, Bossuyt et al., 2004, 
Downs et al., 2017b). The summary estimates from the meta-analyses may still be more 
representative of the diagnostic test performance than estimates from individual studies by 
providing a better guide of uncertainty or variability in performance.   
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Two modelling procedures were used. Modelling procedure A included more variables 
considered a priori as influential and that were associated with performance in the models 
but did not necessarily maximise model fit. Modelling procedure B used automated selection 
of variables with the best model selected by DIC. Procedure B resulted in narrower credible 
intervals but procedure A may be less biased (Altman and Andersen, 1989), and more 
indicative of the heterogeneity in test performance as it truly exists. Commonly, both 
procedures produced similar distributions but on some occasions the posterior distributions 
varied significantly. For example, the estimation of the Se of PCR was much higher using 
modelling procedure B compared to A due to the inclusion of production type in A. 
Modelling using procedure A suggested that PCR is a less sensitive test for bTB in dairy 
cattle compared to non-dairy cattle whereas using procedure B did not. Dairy reactor cattle 
from infected herds are less likely to have visible lesions than non-dairy (O’Hagan et al., 
2015, Downs et al., 2017). This may affect the sensitivity of PCR, which is conditional on the 
Se of necropsy and volume of DNA available (Cardosa et al., 2009). However, differences in 
PCR primer and other methodological factors not included in the models could also explain 
the differences in estimates. Similar estimates for Se were reported in five references where 
performance of PCR was measured in dairy and non-dairy cattle using the same target 
antigen gene sequence (IS6110) (Liebana et al., 1995, Cornejo et al., 1998, Zanini et al., 
2001, Zumarraga et al., 2002, Meikle et al., 2007).   
 
In different studies, performance of the IFN-γ and ELISA blood tests was estimated using 
different algorithms and cut-off values for a positive response (see the footnotes to Tables 6 
and 7 for examples from recent references). It was not possible to determine, in simple 
comparisons, whether differences in performance estimates were related to the test or 
affected by the cut-off value chosen, the population or some other factor. Different research 
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organisations had developed different scales to meet requirements of the specific conditions 
of their target surveillance population. A counter-parameter making use of the fact that Se 
and Sp are approximately inversely related was included in our models to adjust for 
differences in cut-off values, although this will not have eliminated all confounding (EFSA, 
2006, 2008, Greiner et al., 2009). 
 
All estimates for performance in the meta-analyses were relative to a reference standard and 
were therefore influenced by the accuracy of the reference test. The over-riding weakness to 
evaluating a test against a reference standard is that the reference standard itself will be 
imperfect and the test being evaluated can equal but will never be calculated as better than 
the reference standard. Additionally, different tests often perform optimally at different stages 
in the natural history of the disease within an animal (TDR, 2010). Most screening tests use 
immunological markers correlated with early stage disease whereas reference tests are 
commonly based on visible disease that occurs at later stages (Welsh et al., 2005, Pollock et 
al., 2005). This bias was less likely with the estimation of Sp compared to Se because Sp 
analyses were limited to studies with a population sample reported to be bTB free. 
 
Latent class analysis (LCA) would have allowed the estimation of Se and Sp without reliance 
on a reference standard but requires cross-tabulated data for the performance of at least two 
diagnostic tests in two distinct populations or population subgroups with different levels of 
disease prevalence or, alternatively, results from one population and three diagnostic tests 
(Toft et al., 2005). Also LCA generally requires larger sample sizes to achieve similar 
precision. In the systematic review, Bayesian latent class models could be fitted to the results 
of six references compared to 119 references where test performance was evaluated against a 
reference standard (Downs et al., 2017b). Furthermore, LCA is not without methodological 
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limitations. For example, it has been reported that Se estimated through LCA tends to be 
biased towards test Se in the population with the highest disease or infection prevalence (Toft 
et al., 2005).  The Se estimates from the meta-analysis for the SICCT test and IFN-γ test 
using PPD were mostly consistent with Se estimates from LCA studies published between 
2009 and 2015 (Figure 1). There was more heterogeneity between Sp estimated through the 
meta-analysis and Sp estimated through LCA (Figure 2). 
 
The use of LCA data as a prior in the Bayesian regression analysis was also explored. 
However, non-informative priors were preferred because of the paucity of performance 
estimates for most test-types which meant that the studies yielding LCA data were very 
influential. Additionally, data from studies informing the regression priors could not be used 
in the posterior estimation of test performance limiting power. 
 
In conclusion, this study based on a comprehensive systematic literature review provides an 
overview of the empirical evidence for the accuracy of a wide range of contemporary 
diagnostic tests for bTB in cattle. We attempted to control for many factors that may 
influence Se and Sp, but acknowledge that the adjustment will not be perfect. The wide 
credible intervals, particularly for the Se estimates, are likely to be due to the limited number 
of studies with eligible data for some tests and differences in study methodology but may also 
reflect true heterogeneity in performance as Se varies with local conditions. Understanding 
performance characteristics in the context of local conditions is essential for the design of 
effective control strategies and their evaluation.  
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Fig. 1. Sensitivity estimated using Latent Class Analysis in studies published 2009-2015 and from the meta-
analysis 
 
Footnote to Fig. 1. 
a Muller et al., 2009 (Chad) 95% Confidence Interval 
b Clegg et al., 2011 (Republic of Ireland) 95% Credible Intervals 
c EFSA, 2012 (Northern Ireland) 95% Credible Intervals 
d EFSA, 2012 (Republic of Ireland) 95% Credible Intervals 
e Hartnack et al., 2012 (England) 95% Confidence Intervals 
f Praud et al., 2015 (France) 95% Credible Intervals 
g Lopes et al., 2012 (Brazil) 95% Confidence Intervals 
y Meta-analysis, modelling procedure A 95% Credible Intervals 
z Meta-analysis, modelling procedure B 95% Credible Intervals 
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Fig. 2. Specificity estimated using Latent Class Analysis in studies published 2009-2015 and from the meta-
analysis 
 
Footnote to Fig. 2. 
a Muller et al., 2009 (Chad) 95% Confidence Intervals 
b Clegg et al., 2011 (Republic of Ireland) 95% Credible Intervals 
c EFSA, 2012 (Northern Ireland) 95% Credible Intervals 
d EFSA, 2012 (Republic of Ireland) 95% Credible Intervals 
e Hartnack et al., 2012 (England) 95% Confidence Intervals 
f Lopes et al., 2012 (Brazil) 95% Confidence Intervals 
g Praud et al., 2015 (France) 95% Credible Intervals 
y Meta-analysis, modelling procedure A 95% Credible Intervals 
z Meta-analysis, modelling procedure B 95% Credible Intervals 
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Table 1 Variables included in models for estimation of sensitivity 
Test Name Ref. Sampling  World Pub. Prod. PPD Skin test Skin test Diagnostic Culture Post Sp counter SICCT  Rev. Lang. 
Time 
since 
 
test strategy region Year class manu. interp. PPD antigens media mortem parameter test no. 
 
SICCT 
test 
Skin tests with PPD                                 
Single intradermal skin N/N A/N N/N R R N/B A N/N NA NA R NA R R N/N NA 
SICCT test severe A/B N/N N/N A/N N/N A/N N/B N/N NA NA R NA R N/N A/N NA 
SICCT test standard A/B N/N N/N A/N N/N A A/B N NA NA R NA R A/N N/N NA 
Caudal fold A/N A/N R R R R R A/B NA NA R NA R R R NA 
IFN-γ blood tests 
                
IFN-γ Bovine PPD A/B A/N A/B N/N N/N NA NA NA A/B NA NA A/B A/N R R A/N 
IFN-γ Bovine PPD-Avian PPD A/B A/B N/N N/N N/N NA NA NA A/B NA NA A/B N/N R R A/N 
IFN-γ ESAT6/CFP10 A/B A/B A/N N/N N/N NA NA NA A/B NA NA A/N N/B A/N R A/N 
IFN-γ MPB70 A/N A/N N/N N/N A/B NA NA NA A/B NA NA A/B A/B R R A/N 
Antibody detection tests 
                
ELISA Bovine PPD A/B A/N A/N N/N A/N NA NA NA A/B NA NA N/B A/N R R R 
ELISA Bovine PPD-Avian PPD A/B A/N A/N N A/N NA NA NA A/B NA NA N/B A/N R R R 
ELISA MPB70 A/B A/N A/N N A/N NA NA NA A/B NA NA N/B A/N R R R 
LBAA X X X X X NA NA NA NA NA X X X X X X 
Multiplex immunoassay  X X X X X NA NA NA NA NA X X X X X NA 
Glutaraldehyde X X X X X NA NA NA NA NA X X X X X X 
Post mortem 
                
Meat inspection N/N A/B N/N N/N R NA NA NA NA NA A/B NA A/B R A/B NA 
Detailed necropsy N/N A/B N/N N/N N/N NA NA NA NA NA A/B NA A/B R A/B NA 
Microscopic examination N/N R A/N R NA NA NA NA NA NA A/N NA A/B R A/N NA 
Culture A/B R N A/B R NA NA NA NA A/B A/B NA A/B R A/B NA 
PCR A/B A/N A/N A/N NA NA NA NA NA NA A/N NA R R N/N NA 
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Footnote to Table 1 
 
Ref test: reference test; Lang: Language; PPD Manu: PPD manufacturer; Skin Test Interp.: Skin Test Interpretation; LBAA: Latex bead agglutination assay; PCR: 
Polymerase Chain Reaction; A/B: covariate significant for model A and model B, A: covariate significant for model A, B: covariate significant for model B,  N: covariates 
not included in the final model due to: for model A it did not show association in the preliminary analysis  and for model B it was not significant; NA: covariate not 
applicable to the test-type; R: covariate removed before the modelling due to low variability; X: non included in the model since a FEM with no covariates was used due to 
scarce data. See Table 3 for further explanation of variables. 
 
Table 2  Variables included in models for estimation of specificity 
Test Name Ref. Sampling  World Pub. Prod. PPD Skin test Skin test Diagnostic  Cross Freedom Se counter 
  Test strategy region Year class manu. interp. PPD antigens reactivity from infection parameter 
Skin tests with PPD 
                       
Single intradermal test X X X X X X X X NA X X NA 
SICCT test X X X X X X X X NA X X NA 
Caudal fold X X X X X NA NA NA NA X X NA 
IFN-y blood tests 
                       
IFN-γ Bovine PPD A A N/N N/N N/N NA NA NA A/B N/N B A/B 
IFN-γ Bovine PPD-Avian PPD A A A N/N N/N NA NA NA B N/N B A/B 
IFN-γ ESAT6/CFP10 A A A N/N N/N NA NA NA A/B N/N B A/B 
IFN-γ MPB70 A A A A N/N NA NA NA A/B N/N B A/B 
Antibody detection tests 
           
 
ELISA Bovine PPD N/N R N/N N/N R NA NA NA A/B A/B N/N A/B 
ELISA Bovine PPD-Avian 
PDD 
X A X X X NA NA NA B A/B X 
A/B 
LBAA X X X X X NA NA NA NA X X NA 
Multiplex immunoassay  X X X X X NA NA NA X X X NA 
Serological Rapid  X X X X X NA NA NA NA X X NA 
Glutaraldehyde X X X X X NA NA NA NA X X NA 
IFA X X X X X NA NA NA NA X X NA 
Post Mortem                        
Necropsy X X X X X NA NA NA NA X X NA 
Microscopic examination X X X X X NA NA NA NA X X NA 
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PCR X X X X X NA NA NA NA X X NA 
Culture  X X X X X NA NA NA NA X X NA 
 
Footnote to Table 2. 
Ref test: reference test; Lang: Language; PPD Manu: PPD manufacturer; Skin Test Interp.: Skin Test Interpretation; LBAA: Latex bead agglutination assay; IFA: Indirect 
Fluorescent Antibody Test; PCR: Polymerase Chain Reaction; A/B: covariate significant for model A and model B, A: covariate significant for model A, B: covariate 
significant for model B, N: covariates non included in the final model due to: for model A it did not show association in the analysis and for model B it was not significant; 
NA: covariate not applicable to the test-type; R: covariate removed before the modelling due to low variability; X: not included in the model since a Fixed Effects Model 
(FEM) with no covariates was used due to scarce data. See Table 3 for further explanation of variables. 
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Table 3 Covariates with description and binary categories in regression modelling 
Covariate  Description 
UK & Ireland category (baseline 
category, set to 1) 
Other complementary category set 
to 0 
Cross reactivity Cross reactivity with other mycobacteria probable Yes No or unknown 
Culture Media Used to isolate M. bovis Lowenstein-Jensen-Middlebrook Other or unknown 
Diagnostic antigen  Diagnostic antigens in IFN-γ or ELISA blood tests Bovine PPD Other diagnostic antigen 
Diagnostic antigen  Diagnostic antigens in IFN-γ or ELISA blood tests Bovine PPD-Avian PPD Other diagnostic antigen 
Diagnostic antigen  Diagnostic antigens in IFN-γ or ELISA blood tests ESAT6/CFP10 Other diagnostic antigen 
Freedom from Infection 
Level of evidence that population sample free from 
infection (for estimation of specificity) 
From Officially Tuberculosis free 
herd, country or region 
Other evidence cattle are free from 
M. bovis infection 
Language Language in which the reference was published English Other 
Post mortem Diagnostic test conducted after a post mortem Yes No 
Production class Cattle production class Dairy Non-Dairy 
PPD Manufacturer 
Name of manufacturer of purified protein derivative 
given Yes No 
Publication year Year reference was published 2000-2010 Before 2000 
Reference Test Reference test (for estimating specifity) Necropsy or culture Other 
Reviewer Number 
Number of reviewers who reviewed and extracted 
data from the reference 2 1 
Sampling strategy Sampling method to select cattle population 
Probability samping frame 
(random/census)    
Counter parameter 
Estimate of Sp extracted from reference when 
estimating Se and estimate of Se extracted from 
reference when estimating Sp . In Random Effects 
Models only     
SICCT test 
Selection of population sample using SICCT test 
(for estimating Se) No selection using SICCT test 
All animals in population sample are 
SICCT positive 
Skin test interpretation Skin test wheal size 4mm or more Standard Other 
Skin test interpretation Skin test wheal size of 2mm or more Severe Other 
Time since skin test 
Conduct of index blood test in relation to tuberculin 
skin test Before skin test Other 
World region Location of test EUUKI Other 
Footnote to Table 3  
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Variables selected a-priori and included in one or more regression models.   
 
Table 4 Meta-analysis results for sensitivity of diagnostic tests for bovine tuberculosis in cattle  
Test Name References Sensitivity Pooled Models   Model A     Model B     
 
 
Estimates Sensitivity A & B 
 
95% 
 
  95% 
 
  n N Estimate Type Median 
Credible 
Interval 
DIC Median 
Credible 
Interval 
DIC 
Skin tests with PPD 
   
              
Single intradermal skin test 7 16 0.92 REM 0.94 0.49, 1.0 88 0.81 0.53, 0.94 85 
SICCT test standard interpretation 14 38 0.78 REM 0.50 0.26, 0.78 159 0.64 0.48, 0.78 156 
SICCT test severe interpretation 14 38 0.84 REM 0.63 0.40, 0.84 183 0.75 0.61, 0.86 183 
Caudal fold 15 69 0.92 REM 0.76 0.56, 0.89 405 0.96 0.88, 0.98 403 
IFN-y blood tests 
   
    
  
  
  
IFN-γ Bovine 27 166 0.84 REM 0.87 0.72, 0.95 796 0.87 0.76, 0.94 790 
IFN-γ Bovine PPD- Avian PPD 27 166 0.83 REM 0.67 0.49, 0.82 845 0.70 0.55, 0.92 822 
IFN-γ ESAT6/CFP10 27 166 0.84 REM 0.78 0.60, 0.90 842 0.79 0.64, 0.89 816 
IFN-γ MPB70 27 166 0.42 REM 0.10 0.03, 0.25 800 0.16 0.08, 0.30 728 
Antibody detection blood tests 
   
    
  
  
  
ELISA Bovine 22 59 0.62 REM 0.76 0.06, 0.99 362 0.79 0.52, 0.93 328 
ELISA Bovine PPD-Avian PPD 22 59 0.44 REM 0.36 0.01, 0.97 351 0.60 0.31, 0.86 329 
ELISA MPB70 22 59 0.80 REM 0.20 0.01, 0.94 337 0.25 0.05, 0.66 295 
Latex bead agglutination assay 2 3 0.91 FEM 0.91 0.60, 0.98 a b b b 
Multiplex immunoassay  1 5 0.75 FEM 0.74 0.31, 0.95 a b b b 
Glutaraldehyde 1 1 0.85 FEM 0.84 0.42, 0.98 a b b b 
Post Mortem 
   
    
  
  
  
Necropsy (detailed/laboratory) 6 11 0.79 REM 0.96 0.82, 1.00 39 0.96 0.82, 1.00 39 
Necropsy (meat inspection) 6 11 0.46 REM 0.71 0.37, 0.92 39 0.71 0.37, 0.92 39 
Microscopic examination 13 21 0.74 REM 0.63 0.15, 0.93 159 0.66 0.41, 0.84 158 
Culture 8 16 0.55 REM 0.74 0.46, 0.94 101 0.74 0.46, 0.94 101 
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PCR 12 25 0.51 REM 0.14 0.0, 0.98 129 0.86 0.65, 0.96 128 
 
 
 
Footnote for Table 4. 
Estimates are at the animal level. REM: Random Effects Model, FEM: Fixed Effect Model. FEM were fitted for tests with a very sparse data set. For these tests covariates 
were not included in the model and models A and B are identical. DIC: Deviance Information Criterion for comparing models. Severe interpretation: Reaction to Bovine 
tuberculin is positive and the reaction to Avian tuberculin is negative or animals show a positive Bovine reaction more than 2 mm, greater than a positive Avian reaction. 
Standard interpretation in GB: Reaction to Bovine tuberculin is both positive and exceeds the reaction to Avian tuberculin by more than 4 mm. a: Not Applicable. b: Model B 
was only performed for test types that had a REM successfully applied. 
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Table 5 Meta-analysis results for specificity of diagnostic tests for bovine tuberculosis in cattle 
Test Name References Specificity Pooled Models  Model A     Model B     
 
 
Estimates Specificity A & B 
 
95% 
 
  95% 
 
  n N Estimate  Type Median 
Credible 
Interval 
DIC Median 
Credible 
Interval 
DIC 
Skin tests 
   
              
Single Intradermal skin 
test 
4 10 0.89 REM 0.91 0.70, 1.00 29 0.91 0.63, 1.00 30 
SICCT test standard 7 13 1.00 REM 1.00 0.99, 1.00 a 1.00 0.99, 1.00 a 
Caudal fold 2 3 0.99 FEM 1.00 0.92, 1.00 a b b b 
IFN-y blood tests 
   
    
  
  
  
IFN-γ Bovine PPD 19 137 0.91 REM 0.97 0.94, 0.98 647 0.94 0.86, 0.98 649 
IFN-γ Bovine PPD-
Avian PPD 
19 137 0.96 REM 0.98 0.96, 0.99 645 0.94 0.88, 0.97 621 
IFN-γ ESAT6/CFP10 19 137 0.98 REM 0.99 0.99, 1.00 597 0.99 0.98, 1.00 601 
IFN-γ MPB70 19 137 0.93 REM 0.94 0.85, 0.98 639 0.91 0.81, 0.96 641 
Antibody detection blood tests     
  
  
  
ELISA Bovine PPD 12 27 0.96 REM 0.89 0.80, 0.94 142 0.89 0.80, 0.94 142 
ELISA Bovine PPD-
Avian PPD 
12 27 0.98 REM 0.93 0.84, 0.98 141 0.93 0.84, 0.97 141 
LBAA 1 1 1.00 FEM 0.94 0.39, 1.00 a b b b 
Multiplex 
immunoassay  
1 4 0.88 FEM 0.88 0.34, 0.99 a b b b 
Serological Rapid 2 3 0.97 FEM 0.97 0.66, 1.00 a b b b 
Post Mortem 
   
    
  
  
  
Necropsy 1 3 1.00 FEM 1.00 0.99, 1.00 a b b b 
Culture 1 1 1.00 FEM 0.99 0.73, 1.00 a b b b 
Microscopic 
examination 
1 1 1.00 FEM 1.00 0.95, 1.00 a b b b 
PCR 4 5 1.00 FEM 1.00 1.00, 1.00 a b b b 
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Footnote for Table 5. 
Estimates are at the animal level. REM: Random Effects Model, FEM: Fixed Effect Model. FEM were fitted for tests with a very sparse data set. For these tests covariates 
were not included in the model and models A and B are identical. DIC: Deviance Information Criterion for comparing models. Standard interpretation in GB: Reaction to 
bovine tuberculin is both positive and exceeds the reaction to Avian tuberculin by more than 4 mm. a: Not Applicable. b: Model B was only performed for test types that had a 
REM successfully applied. 
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Table 6 Sensitivity reported for skin tests, IFN-γ and ELISA blood tests 2010-2015 
 
Reference Diagnostic reagents 
Reference Standard   (bTB 
infection positive) 
bTB 
infected 
cattle (n) Sensitivity 
Skin tests         
SIT  - severe interpretation 
   
Casal 2014 Bovine PPDa 
Visible lesions and/or positive 
culture 27b 0.59 
SICCT test - severe interpretation       
Karolemeleas 2012 Bovine PPD-Avian PPDc 
Visible lesions and/or positive 
culture d 0.85e 
Casal 2014 Bovine PPD-Avian PPDc 
Visible lesions and/or positive 
culture 27b 0.37 
SICCT test - standard interpretation       
Karolemeleas 2012 Bovine PPD-Avian PPDf 
Visible lesions and/or culture 
positive d 0.81e 
Defined antigen skin test       
Whelan 2010 
ESAT6, CFP10, MPB70, 
MPB83g Positive SICCT testf 34 0.74 
Flores-Villalva 
2012 ESAT6/CFP10h  Positive SICCT testf 63 0.76 
Jones 2012 ESAT6/CFP10+Rv3615ch 
Visible lesions with or without 
positive culture 16 0.75 
Jones 2012 
ESAT6/CFP10 + 
Rv3615c+RV3020ch 
Visible lesions with or without 
positive culture 16 0.88 
IFN-γ blood test         
Purified protein derivative IFN-γ tests       
Jones 2010 Bovine PPDi  Positive SICCT testf 35 0.80 
Schiller 2009 Bovine PPD - Avian PPDj Positive culture and/or lesions 431 0.91 
Marassi 2010 Bovine PPD - Avian PPDj  
Positive SICCT testf (with or 
without) positive culture or 21 0.95  
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PCR  
Antognoli  2011 Bovine PPD - Avian PPDj 
Positive histopathology and 
PCR or positive culture 87 0.84 
Faye 2011 
Bovine PPD - Avian 
PPDk 
Visible lesions with or without 
positive culture and/or PCR 
and/or histology 56 0.93 
Flores-Villalva 
2012 Bovine PPD - Avian PPDl Positive SICCT testf 63 0.89 
Casal 2014 
Bovine PPD - Avian 
PPDm 
Visible lesions or positive 
culture 32 0.88 
Defined antigen IFN-γ blood tests       
Jones 2010 ESAT6/CFP10n Positive SICCT testf 35 0.69 
Faye 2011 ESAT6/CFP10o 
Visible lesions with or without 
positive culture and/or PCR 
and/or histology 58 0.97 
Flores-Villalva 
2012 ESAT6/CFP10p Positive SICCT testf 63 0.70 
Antibody Detection blood tests (ELISA)       
Marassi 2014 MPB70q Positive SICCT testf 9 0.11 
Marassi 2014 MPB83r Positive SICCT testf 9 0.67 
Buddle 2013 MPB70 and MPB83s  
Visible lesions or positive 
culture 38 0.53 
Casal 2014 MPB70 and MPB83t  
Visible lesions and/or positive 
culture 27b 0.70 
Casal 2014 
MPB70, MPB83, ESAT6, 
CFP-10, PPD bovine, 
MPB70t 
Visible lesions and/or positive 
culture 27b 0.85 
Silva 2011 MPT-51u Positive SICCT testf 208 0.55 
Silva 2011 Ag85v Positive SICCT testf 208 0.48 
Silva 2011 BCGw Positive SICCT testf 208 0.82 
Footnote 
Positive cut-off: 
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a: Change in skin fold thickness in response to Bovine PPD >2mm or clinical signs 
b: Herd a in Casal et al. 2014 
c: Change in skin fold thickness in response to Bovine PDD- response to Avian PPD > 2mm 
and/or clinical signs 
d: Not reported in Karolemeleas et al. 2012; approx 500 cattle from 16 herds based on source 
data from Animal and Plant Health Agency  
e: Estimated from logistic regression modelling 
f: Change in skin fold thickness in response to Bovine PDD- response to Avian PPD > 4mm 
g: (Optical Density (OD) Bovine PPD - OD Avian PPD)/(positive control OD - negative 
control OD)>0.1 
h: Change in skin fold thickness > 1mm above response in negative control 
i: Response to Bovine PPD - response to negative control>8.33ng/ml 
j: (OD bovine PPD - OD negative control) AND (Bovine PPD - OD Avian PPD)>0.1 
k: (OD Bovine PPD - OD Avian PPD)/(positive control OD - negative control OD)>0.02 
l: (OD Bovine PPD- OD Avian PPD)/(OD negative control)>2 
m:(OD sample - OD negative control>0.05) AND ((OD Bovine PPD-negative control)>(OD 
Avian - negative control)) 
n:Response to ESAT6/CFP10- Response to negative control>8.33ng/ml 
o: (OD ESAT6/CFP10 - OD negative control)/(positive control OD - negative control 
OD)>0.01 
p: (OD ESAT6/CFP10 - OD negative control)/(positive control OD - negative control OD)>2 
q: OD cut off=0.21 
r: OD cut off=0.25 
s:(OD sample - OD negative control)/(positive control - negative control)> 3 
t: Sample responses to 2 antigens above the individual's threshold 
u:OD cut off=1.301 
v:OD cut off=0.898 
w:OD cut off=1.287 
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Table 7 Specificity reported for skin tests, IFN-γ and ELISA blood tests 2010-2015 
 
Reference Diagnostic reagent 
Reference Standard  
(bTB infection 
negative) 
Uninfected 
cattle Specificity 
Skin tests         
SICCT test - severe interpretation       
Goodchild  2015 Bovine PPD - Avian PPDa 
OTF herds>8 km 
from herds with 
OTFW 1,379,634 1.00 
SICCT test - standard interpretation       
Goodchild  2015 Bovine PPD - Avian PPDb 
OTF herds>8 km 
from herds with 
OTFW 1,379,634 1.00 
Defined antigen skin test       
Whelan 2010 
ESAT6, CFP10, MPB70, 
MPB83c bTB free farms 14 1.00 
Flores-Villalva 
2012 ESAT6/CFP10c  bTB free herd 10 0.90 
Jones 2012 ESAT6/CFP10+Rv3615cc 
 
7 1.00 
Jones 2012 
ESAT6/CFP10 + 
Rv3615c+RV3020cc 
 
7 1.00 
IFN-γ blood test         
Purified protein derivative IFN-γ tests       
Antognoli  2011 Bovine PPD - Avian PPDd Acredited bTB free 4123 0.91 
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herds 
Faye 2011 Bovine PPD - Avian PPDe 
Herds bTB free>10 
years and from bTB 
free region 482 0.98 
Defined antigen IFN-γ  blood tests        
Faye 2011 ESAT6/CFP10f 
Herds bTB free>10 
years and from bTB 
free region 472 0.96 
Antibody detection blood tests (ELISA)       
Casal 2014 MPB70 and MPB83g  
Officially 
Tuberculosis Free > 4 
years 60 1.00 
Casal 2014 
MPB70, MPB83, ESAT6, 
CFP-10, PPD bovine, 
MPB70h 
Officially 
Tuberculosis Free > 4 
years 60 0.98 
Silva 2012 MPT-51i 
bTB free herds from 
an area bTB is 
endemic 54 0.52 
Silva 2012 AG85j 
bTB free herds from 
an area bTB is 
endemic 54 0.89 
Silva 2012 BCGk 
bTB free herds from 
an area bTB is 
endemic 54 0.91 
Positive cut-off: 
a: Change in skin fold thickness in response to Bovine PDD- response to Avian PPD > 2mm 
b: Change in skin fold thickness in response to Bovine PDD- response to Avian PPD > 4mm 
c: Change in skin fold thickness > 1mm above response in negative control  
d: (Optical Density (OD) bovine PPD - OD negative control) AND (Bovine PPD - OD Avian 
PPD)>0.1 
e: (OD Bovine PPD - OD Avian PPD)/(positive control OD - negative control OD)>0.02 
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f: (OD ESAT6/CFP10 - OD negative control)/(positive control OD - negative control OD)>0.1 
g:(OD sample - OD negative control)/(positive control - negative control)> 3 
h: Sample responses to 4 antigens above the individual's threshold 
i:OD cut off=1.301 
j:OD cut off=0.898 
k:OD cut off=1.287 
 
 
 
 
